Biogen is halting the development and commercialization of the Alzheimer’s drug Aduhelm, which drew intense scrutiny of its U.S. regulatory process due to concerns about whether its benefits outweighed its risks.
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global economy and business, trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs & funds, bonds & rates and much more. The Stock Market News works with public RSS feeds of the best business, finance and economic news websites, personal blogs providing automatically generated list of financial news links referring to its sources. Disclaimer: By using any material of this website, you acknowledge and agree that The Stock Market News is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.
